The cost of universal screening for gestational diabetes mellitus in Ireland.

Hdl Handle:
http://hdl.handle.net/10147/218150
Title:
The cost of universal screening for gestational diabetes mellitus in Ireland.
Authors:
Gillespie, P; O'Neill, C; Avalos, G; O'Reilly, M; Dunne, F
Affiliation:
School of Business and Economics, National University of Ireland, Galway, Ireland. paddy.gillespie@nuigalway.ie
Citation:
The cost of universal screening for gestational diabetes mellitus in Ireland. 2011, 28 (8):912-8 Diabet. Med.
Journal:
Diabetic medicine : a journal of the British Diabetic Association
Issue Date:
Aug-2011
URI:
http://hdl.handle.net/10147/218150
DOI:
10.1111/j.1464-5491.2011.03293.x
PubMed ID:
21418093
Abstract:
To estimate the costs associated with universal screening for gestational diabetes mellitus in Ireland.; Bottom-up, prevalence-based cost analysis. Healthcare activity identified using the Atlantic Diabetes in Pregnancy (ATLANTIC DIP) database was grouped into five categories: screening and testing, gestational diabetes treatment, prenatal care, delivery care and neonatal care. A vector of unit cost data (euros in 2008 prices) was applied to specified resource use and the total healthcare cost calculated. A series of one-way and probabilistic sensitivity analyses were undertaken to explore the uncertainty in the analysis.; When individual resource components were valued and aggregated, the total healthcare cost of gestational diabetes in Ireland was estimated at €12 433 320 (95% CI €9 298 228-16 778 193). The average cost per case detected was €1621 (95% CI €524-2603) and the average total cost per case detected and treated was €11 903 (95% CI €7645-16 121).; This research provides the first estimates of the healthcare costs associated with gestational diabetes mellitus in Ireland. Further research is required to determine the cost-effectiveness of gestational diabetes screening in the region with a view to improving resource allocation in this area in the future.
Language:
en
MeSH:
Adult; Cost-Benefit Analysis; Diabetes, Gestational; Female; Glucose Tolerance Test; Humans; Infant, Newborn; Ireland; Mass Screening; Models, Economic; Pregnancy; Prenatal Care; Probability
ISSN:
1464-5491
Ethical Approval:
N/A

Full metadata record

DC FieldValue Language
dc.contributor.authorGillespie, P-
dc.contributor.authorO'Neill, C-
dc.contributor.authorAvalos, G-
dc.contributor.authorO'Reilly, M-
dc.contributor.authorDunne, F-
dc.date.accessioned2012-04-11T11:04:56Z-
dc.date.available2012-04-11T11:04:56Z-
dc.date.issued2011-08-
dc.identifier.citationThe cost of universal screening for gestational diabetes mellitus in Ireland. 2011, 28 (8):912-8 Diabet. Med.-
dc.identifier.issn1464-5491-
dc.identifier.pmid21418093-
dc.identifier.doi10.1111/j.1464-5491.2011.03293.x-
dc.identifier.urihttp://hdl.handle.net/10147/218150-
dc.description.abstractTo estimate the costs associated with universal screening for gestational diabetes mellitus in Ireland.-
dc.description.abstractBottom-up, prevalence-based cost analysis. Healthcare activity identified using the Atlantic Diabetes in Pregnancy (ATLANTIC DIP) database was grouped into five categories: screening and testing, gestational diabetes treatment, prenatal care, delivery care and neonatal care. A vector of unit cost data (euros in 2008 prices) was applied to specified resource use and the total healthcare cost calculated. A series of one-way and probabilistic sensitivity analyses were undertaken to explore the uncertainty in the analysis.-
dc.description.abstractWhen individual resource components were valued and aggregated, the total healthcare cost of gestational diabetes in Ireland was estimated at €12 433 320 (95% CI €9 298 228-16 778 193). The average cost per case detected was €1621 (95% CI €524-2603) and the average total cost per case detected and treated was €11 903 (95% CI €7645-16 121).-
dc.description.abstractThis research provides the first estimates of the healthcare costs associated with gestational diabetes mellitus in Ireland. Further research is required to determine the cost-effectiveness of gestational diabetes screening in the region with a view to improving resource allocation in this area in the future.-
dc.language.isoen-
dc.rightsArchived with thanks to Diabetic medicine : a journal of the British Diabetic Associationen_GB
dc.subject.meshAdult-
dc.subject.meshCost-Benefit Analysis-
dc.subject.meshDiabetes, Gestational-
dc.subject.meshFemale-
dc.subject.meshGlucose Tolerance Test-
dc.subject.meshHumans-
dc.subject.meshInfant, Newborn-
dc.subject.meshIreland-
dc.subject.meshMass Screening-
dc.subject.meshModels, Economic-
dc.subject.meshPregnancy-
dc.subject.meshPrenatal Care-
dc.subject.meshProbability-
dc.titleThe cost of universal screening for gestational diabetes mellitus in Ireland.en_GB
dc.contributor.departmentSchool of Business and Economics, National University of Ireland, Galway, Ireland. paddy.gillespie@nuigalway.ie-
dc.identifier.journalDiabetic medicine : a journal of the British Diabetic Association-
dc.type.qualificationlevelN/Aen
cr.approval.ethicalN/Aen
dc.description.provinceConnacht-
dc.description.provinceConnachten

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.